Merck Canada Sues To Block Mylan's Generic Singulair
Merck Canada Inc. on Thursday sued Mylan Pharmaceuticals Inc. in New Jersey federal court for allegedly infringing a Merck patent when it sought U.S. Food and Drug Administration approval for a...To view the full article, register now.
Already a subscriber? Click here to view full article